Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 265

1.

Platelet glycoprotein VI promotes metastasis through interaction with cancer cell-derived Galectin-3.

Mammadova-Bach E, Gil-Pulido J, Sarukhanyan E, Burkard P, Shityakov S, Schonhart C, Stegner D, Remer K, Nurden P, Nurden AT, Dandekar T, Nehez L, Dank M, Braun A, Mezzano D, Abrams SI, Nieswandt B.

Blood. 2020 Feb 7. pii: blood.2019002649. doi: 10.1182/blood.2019002649. [Epub ahead of print]

PMID:
32040544
2.

A Glanzmann thrombasthenia family associated with a TUBB1-related macrothrombocytopenia.

Guillet B, Bayart S, Pillois X, Nurden P, Caen JP, Nurden AT.

J Thromb Haemost. 2019 Dec;17(12):2211-2215. doi: 10.1111/jth.14622. Epub 2019 Sep 29.

PMID:
31565851
3.

Clinical significance of altered collagen-receptor functioning in platelets with emphasis on glycoprotein VI.

Nurden AT.

Blood Rev. 2019 Nov;38:100592. doi: 10.1016/j.blre.2019.100592. Epub 2019 Jul 22. Review.

PMID:
31351674
4.

Is the mysterious platelet receptor GPV an unsuspected major target for platelet autoantibodies?

Nurden P, Nurden AT.

Haematologica. 2019 Jun;104(6):1103-1105. doi: 10.3324/haematol.2018.214908. No abstract available.

5.

Acquired Glanzmann thrombasthenia: From antibodies to anti-platelet drugs.

Nurden AT.

Blood Rev. 2019 Jul;36:10-22. doi: 10.1016/j.blre.2019.03.004. Epub 2019 Mar 20. Review.

PMID:
31010659
6.

Autologous fibrin scaffolds: When platelet- and plasma-derived biomolecules meet fibrin.

Anitua E, Nurden P, Prado R, Nurden AT, Padilla S.

Biomaterials. 2019 Feb;192:440-460. doi: 10.1016/j.biomaterials.2018.11.029. Epub 2018 Nov 21. Review.

PMID:
30500725
7.

A mutation of the human EPHB2 gene leads to a major platelet functional defect.

Berrou E, Soukaseum C, Favier R, Adam F, Elaib Z, Kauskot A, Bordet JC, Ballerini P, Loyau S, Feng M, Dias K, Muheidli A, Girault S, Nurden AT, Turro E, Ouwehand WH, Denis CV, Jandrot-Perrus M, Rosa JP, Nurden P, Bryckaert M.

Blood. 2018 Nov 8;132(19):2067-2077. doi: 10.1182/blood-2018-04-845644. Epub 2018 Sep 13.

PMID:
30213874
8.

Personal reflections on the early contributions of Gus Born to platelet research.

Nurden AT.

Platelets. 2018 Sep 5:1-5. doi: 10.1080/09537104.2018.1513477. [Epub ahead of print]

PMID:
30183446
9.

Phenotype analysis and clinical management in a large family with a novel truncating mutation in RASGRP2, the CalDAG-GEFI encoding gene.

Desai A, Bergmeier W, Canault M, Alessi MC, Paul DS, Nurden P, Pillois X, Jy W, Ahn YS, Nurden AT.

Res Pract Thromb Haemost. 2017 Jun 20;1(1):128-133. doi: 10.1002/rth2.12019. eCollection 2017 Jul.

10.

Acquired Antibodies to αIIbβ3 in Glanzmann Thrombasthenia: From Transfusion and Pregnancy to Bone Marrow Transplants and Beyond.

Nurden AT.

Transfus Med Rev. 2018 May 23. pii: S0887-7963(18)30037-3. doi: 10.1016/j.tmrv.2018.05.002. [Epub ahead of print] Review.

PMID:
29884513
11.

Professor Gustav Victor Rudolph Born (29 July 1921 - 16 April 2018).

Nurden AT.

J Thromb Haemost. 2018 Jun;16(6):1250-1251. doi: 10.1111/jth.14152. Epub 2018 May 24. No abstract available.

PMID:
29799167
12.

A novel variant Glanzmann thrombasthenia due to co-inheritance of a loss- and a gain-of-function mutation of ITGB3: evidence of a dominant effect of gain-of-function mutations.

Bury L, Zetterberg E, Leinøe EB, Falcinelli E, Marturano A, Manni G, Nurden AT, Gresele P.

Haematologica. 2018 Jun;103(6):e259-e263. doi: 10.3324/haematol.2017.180927. Epub 2018 Feb 8. No abstract available.

13.

In silico analysis of structural modifications in and around the integrin αIIb genu caused by ITGA2B variants in human platelets with emphasis on Glanzmann thrombasthenia.

Pillois X, Peters P, Segers K, Nurden AT.

Mol Genet Genomic Med. 2018 Mar;6(2):249-260. doi: 10.1002/mgg3.365. Epub 2018 Jan 31.

14.

An intracytoplasmic β3 Leu718 deletion in a patient with a novel platelet phenotype.

Nurden P, Bordet JC, Pillois X, Nurden AT.

Blood Adv. 2017 Mar 10;1(8):494-499. doi: 10.1182/bloodadvances.2016002808. eCollection 2017 Mar 14.

15.

High-throughput sequencing for rapid diagnosis of inherited platelet disorders: a case for a European consensus.

Nurden AT, Nurden P.

Haematologica. 2018 Jan;103(1):6-8. doi: 10.3324/haematol.2017.182295. No abstract available.

16.

ITGA2B and ITGB3 gene mutations associated with Glanzmann thrombasthenia.

Nurden AT, Pillois X.

Platelets. 2018 Jan;29(1):98-101. doi: 10.1080/09537104.2017.1371291. Epub 2017 Nov 10. Review. No abstract available.

PMID:
29125375
17.

Peripartum bleeding management in a patient with CalDAG-GEFI deficiency.

Canault M, Saultier P, Fauré S, Poggi M, Nurden AT, Nurden P, Morange PE, Alessi MC, Gris JC.

Haemophilia. 2017 Nov;23(6):e533-e535. doi: 10.1111/hae.13352. Epub 2017 Oct 4. No abstract available.

PMID:
28976076
18.

The biology of the platelet with special reference to inflammation, wound healing and immunity.

Nurden AT.

Front Biosci (Landmark Ed). 2018 Jan 1;23:726-751. Review.

PMID:
28930569
19.

Marked bleeding diathesis in patients with platelet dysfunction due to a novel mutation in RASGRP2, encoding CalDAG-GEFI (p.Gly305Asp).

Bermejo E, Alberto MF, Paul DS, Cook AA, Nurden P, Sanchez Luceros A, Nurden AT, Bergmeier W.

Platelets. 2018 Jan;29(1):84-86. doi: 10.1080/09537104.2017.1332759. Epub 2017 Jul 20.

20.

A Cdc42/RhoA regulatory circuit downstream of glycoprotein Ib guides transendothelial platelet biogenesis.

Dütting S, Gaits-Iacovoni F, Stegner D, Popp M, Antkowiak A, van Eeuwijk JMM, Nurden P, Stritt S, Heib T, Aurbach K, Angay O, Cherpokova D, Heinz N, Baig AA, Gorelashvili MG, Gerner F, Heinze KG, Ware J, Krohne G, Ruggeri ZM, Nurden AT, Schulze H, Modlich U, Pleines I, Brakebusch C, Nieswandt B.

Nat Commun. 2017 Jun 15;8:15838. doi: 10.1038/ncomms15838.

Supplemental Content

Loading ...
Support Center